This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Forendo Pharma Oy
Drug Names(s): 17ß-HSD1 inhibitor, 17ß-hydroxysteroid-dehydrogenase isoform 1 inhibitor, HM-102
Description: This compound is an inhibitor of 17ß-hydroxysteroid dehydrogenase isoform 1 (17ß-HSD1), an enzyme responsible for catalyzing the final step in the conversion of estrone to estradiol.
Forendo and Hormos
In June 2013, Forendo announced that it has acquired from Hormos Medical the drug development programs for endometriosis (17-HSD) and male low testosterone (fispemifene).
Additional information available to subscribers only: